Boston Scientific has agreed to buy thrombectomy company Penumbra for about $15 billion in cash and stock in a deal that bolsters its cardiovascular portfolio.
Source link
Boston Scientific to Buy Penumbra for $15 Billion in Cash, Stock
Date:
More like thisRelated
Will Taste of Country RISER Ben Gallaher Lead the Week’s Videos?
Ben Gallaher has just released an acoustic performance video...
Repsol Regains Control of Venezuela Oil Fields, Aims to Boost Production
The company aims to increase gross oil production in...
Spurs 2-2 Brighton (Apr 18, 2026) Game Analysis
Tottenham remain in the Premier League relegation zone after...
California bear-suit luxury car scam ends in insurance fraud sentences for 3
LOS ANGELES — Three people in California have been...